Risks and benefits of increased nut consumption: Cardiovascular health benefits outweigh the burden of carcinogenic effects attributed to aflatoxin B1 exposure

Nutrients

Volumn 9, Issue 12, 2017, Pages

  Eneroth, Hanna ^a   Wallin, Stina ^a   Leander, Karin ^b   Sommar, Johan Nilsson ^c   Åkesson, Agneta ^b  

^a National Food Agency   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Aflatoxin; Cardiovascular disease; Disability adjusted life years; Healthy diet; Liver cancer; Myocardial infarction; Nuts; Risk and benefit assessment; Stroke

Indexed keywords

AFLATOXIN B1; CARCINOGEN; TRACE ELEMENT;

ADULT; AGED; AORTIC ANEURYSM; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIET; DISABILITY-ADJUSTED LIFE YEAR; DRUG EXPOSURE; FEMALE; FOOD INTAKE; HEART ARREST; HEART FAILURE; HEART INFARCTION; HUMAN; LIFE EXPECTANCY; LIVER CANCER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; NUT; NUTRIENT UPTAKE; PISTACHIO NUT; ANALYSIS; CARDIOVASCULAR SYSTEM; CHEMICALLY INDUCED; FOOD CONTAMINATION; FOOD CONTROL; INCIDENCE; LIVER TUMOR; MICROBIOLOGY; RISK ASSESSMENT; SWEDEN;

AFLATOXIN B1; CARCINOGENS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIET SURVEYS; FEMALE; FOOD CONTAMINATION; FOOD MICROBIOLOGY; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MICRONUTRIENTS; MIDDLE AGED; NUTS; RISK ASSESSMENT; SWEDEN;

EID: 85038250696     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9121355     Document Type: Article

References (43)

1. Aune, D., Keum, N., Giovannucci, E., Fadnes, L.T., Boffetta, P., Greenwood, D.C., Tonstad, S., Vatten, L.J., Riboli, E., Norat, T. Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: A systematic review and dose-response meta-analysis of prospective studies. BMC Med. 2016, 14, 207.
2. Mayhew, A.J., de Souza, R.J., Meyre, D., Anand, S.S., Mente, A. A systematic review and meta-analysis of nut consumption and incident risk of CVD and all-cause mortality. Br. J. Nutr. 2016, 115, 212-225.
3. Bechthold, A., Boeing, H., Schwedhelm, C., Hoffmann, G., Knuppel, S., Iqbal, K., De Henauw, S., Michels, N., Devleesschauwer, B., Schlesinger, S., et al. Food groups and risk of coronary heart disease, stroke and heart failure: A systematic review and dose-response meta-analysis of prospective studies. Crit. Rev. Food Sci. Nutr. 2017, 1-20.
4. Micha, R., Shulkin, M.L., Penalvo, J.L., Khatibzadeh, S., Singh, G.M., Rao, M., Fahimi, S., Powles, J., Mozaffarian, D. Etiologic effects and optimal intakes of foods and nutrients for risk of cardiovascular diseases and diabetes: Systematic reviews and meta-analyses from the nutrition and chronic diseases expert group (nutricode). PLoS ONE 2017, 12, e0175149.
5. Schwingshackl, L., Schwedhelm, C., Hoffmann, G., Lampousi, A.M., Knuppel, S., Iqbal, K., Bechthold, A., Schlesinger, S., Boeing, H. Food groups and risk of all-cause mortality: A systematic review and meta-analysis of prospective studies. Am. J. Clin. Nutr. 2017, 105, 1462-1473.
6. Del Gobbo, L.C., Falk, M.C., Feldman, R., Lewis, K., Mozaffarian, D. Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: Systematic review, meta-analysis, and dose-response of 61 controlled intervention trials. Am. J. Clin. Nutr. 2015, 102, 1347-1356.
7. Estruch, R., Ros, E., Salas-Salvado, J., Covas, M.I., Corella, D., Aros, F., Gomez-Gracia, E., Ruiz-Gutierrez, V., Fiol, M., Lapetra, J., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 2013, 368, 1279-1290.
8. EFSA. Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to the potential increase of consumer health risk by a possible increase of the existing maximum levels for aflatoxins in almonds, hazelnuts and pistachios and derived products. EFSA J. 2007, 446, 1-127.
9. EFSA. Statement of the scientific panel on contaminants in the food chain on a request from the European Commission on the effects on public health of an increase of the levels for aflatoxin total from 4 μg/kg to 10 μg/kg for tree nuts other than almonds, hazelnuts and pistachios. EFSA J. 2009, 1168, 1-11.
10. World Health Organization, Joint FAO/WHO Expert Committee on Food Additives. Evaluation of Certain Contaminants in Food: Eighty-Third Report of the Joint FAO/WHO Expert Committee on Food Additives, World Health Organization: Geneva, Switzerland, 2017, pp. 11-40.
11. Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., Bray, F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 2015, 136, E359-E386.
12. Liu, Y., Chang, C.C., Marsh, G.M., Wu, F. Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis. Eur. J. Cancer 2012, 48, 2125-2136.
13. Joint FAO/WHO Expert Committee on Food Additives. In Summary and Conclusions from the Eighty-Third Meeting. Available online: http://www.fao.org/3/a-bq821e.pdf (accessed on 30 October 2017).
14. Boobis, A., Chiodini, A., Hoekstra, J., Lagiou, P., Przyrembel, H., Schlatter, J., Schutte, K., Verhagen, H., Watzl, B. Critical appraisal of the assessment of benefits and risks for foods, ‘BRAFO consensus working group’. Food Chem. Toxicol. 2013, 55, 659-675.
15. Riksmaten-Vuxna 2010-11 Ivsmedels-och Näringsintag Bland Vuxna i Sverige (Dietary Habits and Nutrient Intake in Sweden 2010-11). Available online: https://www.livsmedelsverket.se/globalassets/ matvanor-halsa-miljo/kostrad-matvanor/matvaneundersokningar/riksmaten_2010_20111.pdf (accessed on 30 October 2017).
16. Wilkins, E., Wilson, L., Wickramasinghe, K., Bhatnagar, P., Leal, J., Luengo-Fernandez, R., Burns, R., Rayner, M., Townsend, N. European Cardiovascular Disease Statistics 2017, European Heart Network: Brussels, Belgium, 2017.
17. Statistics Sweden. Statistikdatabasen (Population by Region, Age and Sex 2006-2016). Available online: http://www.Statistikdatabasen.Scb.Se/pxweb/sv/ssd/start__be__be0101__be0101d/medelfolkfodelsear/?Rxid=914a6b1b-2534-4663-8681-bf4302f146fb (accessed on 18 August 2017).
18. Townsend, N., Wilson, L., Bhatnagar, P., Wickramasinghe, K., Rayner, M., Nichols, M. Cardiovascular disease in Europe: Epidemiological update 2016. Eur. Heart J. 2016, 37, 3232-3245.
19. Roth, G.A., Johnson, C., Abajobir, A., Abd-Allah, F., Abera, S.F., Abyu, G., Ahmed, M., Aksut, B., Alam, T., Alam, K., et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J. Am. Coll. Cardiol. 2017.
20. National Board of Health and Welfare and the Swedish Cancer Society. Cancer i Siffror 2013 (Cancer in Numbers 2013). Available online: http://www.socialstyrelsen.se/publikationer2013/2013-6-5 (accessed on 30 October 2017).
21. Global Burden of Disease 2004 Update: DisabilityWeights for Diseases and Conditions. Available online: http://www.who.int/healthinfo/global_burden_disease/GBD2004_DisabilityWeights.pdf (accessed on 30 October 2017).
22. Smolina, K., Wright, F.L., Rayner, M., Goldacre, M.J. Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010. Circ. Cardiovasc. Qual. Outcomes 2012, 5, 532-540.
23. Eriksson, M., Carlberg, B., Eliasson, M. The disparity in long-term survival after a first stroke in patients with and without diabetes persists: The Northern Sweden Monica study. Cerebrovasc. Dis. 2012, 34, 153-160.
24. National Board of Health and Welfare. Statistikdatabasen (National Population Statistics). Available online: http://www.Socialstyrelsen.Se/statistik/statistikdatabas/ (accessed on 18 August 2017).
25. EFSA. Opinion of the scientific committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic. EFSA J. 2005, 282, 1-31.
26. Life Expectancy in Sweden 2011-2015. Available online: https://www.scb.se/Statistik/_Publikationer/ BE0701_2016A01R_BR_BE51BR1604.pdf (accessed on 30 October 2017).
27. Bao, Y., Han, J., Hu, F.B., Giovannucci, E.L., Stampfer, M.J., Willett, W.C., Fuchs, C.S. Association of nut consumption with total and cause-specific mortality. N. Engl. J. Med. 2013, 369, 2001-2011.
28. Brown, R.C., Tey, S.L., Gray, A.R., Chisholm, A., Smith, C., Fleming, E., Parnell, W. Nut consumption is associated with better nutrient intakes: Results from the 2008/09 New Zealand adult nutrition survey. Br. J. Nutr. 2016, 115, 105-112.
29. Guasch-Ferré, M., Liu, X., Malik, V.S., Sun, Q., Willett, W.C., Manson, J.E., Rexrode, K.M., Li, Y., Hu, F.B., Bhupathiraju, S.N. Nut consumption and risk of cardiovascular disease. J. Am. Coll. Cardiol. 2017, 70, 2519-2532.
30. Nordic Nutrition Recommendations 2012: Integrating Nutrition and Physical Activity. Available online: http://www.norden.org/en/theme/former-themes/themes-2016/nordic-nutrition-recommendation/ nordic-nutrition-recommendations-2012 (accessed on 30 October 2017).
31. Fats and Fatty Acids in Human Nutrition. Available online: http://www.fao.org/3/a-i1953e.pdf (accessed on 30 October 2017).
32. Schwingshackl, L., Hoffmann, G., Lampousi, A.M., Knuppel, S., Iqbal, K., Schwedhelm, C., Bechthold, A., Schlesinger, S., Boeing, H. Food groups and risk of type 2 diabetes mellitus: A systematic review and meta-analysis of prospective studies. Eur. J. Epidemiol. 2017, 32, 363-375.
33. Fogelholm, M., Anderssen, S., Gunnarsdottir, I., Lahti-Koski, M. Dietary macronutrients and food consumption as determinants of long-term weight change in adult populations: A systematic literature review. Food Nutr. Res. 2012, 56.
34. Flores-Mateo, G., Rojas-Rueda, D., Basora, J., Ros, E., Salas-Salvado, J. Nut intake and adiposity: Meta-analysis of clinical trials. Am. J. Clin. Nutr. 2013, 97, 1346-1355.
35. National Food Agency. Risk-och Nyttovärdering av Nötter-Sammanställning av Hälsoeffekter av Nötkonsumtion (Risk-and Benefit Assessment of Nuts-A Summary of Health Effects of nut Consumption). Report 16:2014. National Food Agency: Uppsala, Sweden, 2014. Available online: https://www.livsmedelsverket.se/globalassets/rapporter/2014/2014_livsmedelsverket_16_risk_ nyttovardering_notter.pdf (accessed on 30 October 2017).
36. Turner, P., Campbell, D. Implementing primary prevention for peanut allergy at a population level. JAMA 2017, 317, 1111-1112.
37. Ludvigsson, J.F., Almqvist, C., Bonamy, A.-K.E., Ljung, R., Michaëlsson, K., Neovius, M., Stephansson, O., Ye, W. Registers of the Swedish total population and their use in medical research. Eur. J. Epidemiol. 2016, 31, 125-136.
38. Ludvigsson, J.F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.L., Reuterwall, C., Heurgren, M., Olausson, P.O. External review and validation of the Swedish national inpatient register. BMC Public Health 2011, 11, 450.
39. GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the global burden of disease study 2016. Lancet 2017, 390, 1260-1344.
40. Salomon, J.A., Haagsma, J.A., Davis, A., de Noordhout, C.M., Polinder, S., Havelaar, A.H., Cassini, A., Devleesschauwer, B., Kretzschmar, M., Speybroeck, N., et al. Disability weights for the global burden of disease 2013 study. Lancet Glob. Health 2015, 3, e712-e723.
41. Busch, K., Kovamees, J., Söderholm, J. Prevalence of hepatitis C and presence of comorbidities in Sweden: A nationwide population-based register study. Value Health 2015, 18, A575-A576.
42. Struve, J., Giesecke, J., Olcen, P., von Sydow, M., Weiland, O. Prevalence of hepatitis B virus markers in Sweden: A community-based serosurvey of 4000 young Swedish adults. Am. J. Epidemiol. 1992, 135, 409-417.
43. National Food Agency. Livsmedelsdatabasen. Food Database Search for Nutrients. Available online: http://www7.Slv.Se/soknaringsinnehall/ (accessed on 15 September 2017).